Clinical Trials Logo

Clinical Trial Summary

CTLA4 and LRBA deficiencies are rare genetic disorders, recently described, and associated with multiple clinical features. It ranges from recurrent infections, auto-immunity, and organ infiltration with lymphocytes. Neurologic syndroms are described in up to 30% of patients, yet they are poorly defined to date. Early recognition of a specific pattern can be important, given that there is a targeted therapy in this situation.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05040256
Study type Observational
Source University Hospital, Montpellier
Status Active, not recruiting
Start date February 1, 2021
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04377867 - New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies